Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities

被引:111
作者
Rock, Wasseem [3 ]
Rosenblat, Mira [1 ,2 ]
Miller-Lotan, Rachel [4 ]
Levy, Andrew P. [4 ]
Elias, Mazen [3 ]
Aviram, Michael [1 ,2 ]
机构
[1] Technion Israel Inst Technol, Rappaport Fac Med, Lipid Res Lab, Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel
[3] HaEmek Med Ctr, Internal Med Dept C, Afula, Israel
[4] Technion Israel Inst Technol, Fac Med, Dept Anat & Cell Biol, Haifa, Israel
关键词
pomegranate; polyphenol; ellagitannins; punicalagin; HDL; paraoxonase; 1; diabetes mellitus;
D O I
10.1021/jf801756x
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Association of paraoxonase 1 (PON1) with high-density lipoprotein (HDL) stabilizes the enzyme. In diabetic patients, PON1 dissociates from HDL and, as a consequence, is less biologically active. Our aim was to investigate the effects of Wonderful variety pomegranate juice (WPJ) and pomegranate polyphenol extract (WPOMxI) consumption on PON1 association with HDL in diabetic patients. Thirty patients with type 2 diabetes mellitus participated in the study. Ten male patients and 10 female patients received concentrated WPJ (50 mL/day for 4 weeks), while another group of 10 male patients received WPOMxI (5 mL/day for 6 weeks). There were no significant effects of WPJ or WPOMxI consumption on fasting blood glucose or hemoglobin A1c levels. After 4 weeks of WPJ consumption by male patients, basal serum oxidative stress was significantly decreased by 35%, whereas serum concentrations of thiol groups significantly increased by 25%. Moreover, HDL-associated POW arylesterase, paraoxonase, and lactonase activities increased significantly after WPJ consumption by 34-45%, as compared to the baseline levels. POW protein binding to HDL was significantly increased by 30% following WPJ consumption, and the enzyme became more stable. In male patients that consumed WPOMxI and in female patients that consumed PJ, a similar pattern was observed, although to a lesser extent. We conclude that WPJ as well as WPOMxI consumption by diabetic patients does not worsen their diabetic parameters. Furthermore, WPJ as well as WPOMxI consumption contribute to PON1 stabilization, increased association with HDL, and enhanced catalytic activities. These beneficial effects of pomegranate consumption on serum POW stability and activity could lead to retardation of atherosclerosis development in diabetic patients.
引用
收藏
页码:8704 / 8713
页数:10
相关论文
共 44 条
[1]   PLASMA-LIPOPROTEIN SEPARATION BY DISCONTINUOUS DENSITY GRADIENT ULTRA-CENTRIFUGATION IN HYPERLIPOPROTEINEMIC PATIENTS [J].
AVIRAM, M .
BIOCHEMICAL MEDICINE, 1983, 30 (01) :111-118
[2]   Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development [J].
Aviram, M ;
Rosenblat, M .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 (09) :1304-1316
[3]   Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation [J].
Aviram, M ;
Rosenblat, M ;
Gaitini, D ;
Nitecki, S ;
Hoffman, A ;
Dornfeld, L ;
Volkova, N ;
Presser, D ;
Attias, J ;
Liker, H ;
Hayek, T .
CLINICAL NUTRITION, 2004, 23 (03) :423-433
[4]   Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[5]  
Aviram M, 2000, AM J CLIN NUTR, V71, P1062
[6]   Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic:: Studies in vivo in atherosclerotic apolipoprotein E-deficient (Eo) mice and in vitro in cultured macrophages and upoproteins [J].
Aviram, Michael ;
Volkova, Nina ;
Coleman, Raymond ;
Dreher, Mark ;
Reddy, Muntha Kesava ;
Ferreira, Daneel ;
Rosenblat, Mira .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, 56 (03) :1148-1157
[7]   The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[8]  
Bernhard D, 2007, CURR MED CHEM, V14, P1703
[9]  
BOWMAN BH, 1982, ADV HUM GENET, V12, P453
[10]  
Buege J A, 1978, Methods Enzymol, V52, P302